Pharmaceuticals
7 companies under coverage.
Pharmaceuticals
Viatris Inc (VTRS)
The bull case — 'Bull — Blockbuster / Pipeline Re-Rate' (8% weight) — targets $36, +126% vs spot. It needs the multiple to hold or expand.
Zoetis Inc (ZTS)
The bull case — 'Bull — Premium Re-Rate' (8% weight) — targets $135, +87% vs spot. It needs the multiple to hold or expand.
Bristol-Myers Squibb Company (BMY)
The bull case — 'Bull — Blockbuster / Pipeline Re-Rate' (8% weight) — targets $101, +75% vs spot. It needs the multiple to hold or expand.
Pfizer Inc (PFE)
The bull case — 'Bull — Blockbuster / Pipeline Re-Rate' (8% weight) — targets $41, +70% vs spot. It needs the multiple to hold or expand.
Johnson & Johnson (JNJ)
The bull case — 'Bull — Blockbuster / Pipeline Re-Rate' (8% weight) — targets $430, +69% vs spot. It needs the multiple to hold or expand.
Merck & Company Inc (MRK)
The bull case — 'Bull — Blockbuster / Pipeline Re-Rate' (8% weight) — targets $224, +74% vs spot. It needs the multiple to hold or expand.
Eli Lilly and Company (LLY)
The bull case — 'Bull — Blockbuster / Pipeline Re-Rate' (8% weight) — targets $1,992, +66% vs spot. It needs the multiple to hold or expand.